IHS Chemical Week

World News and Views :: Top of the News

Johnson & Johnson to Buy Remaining Stake in Crucell for €1.75 Billion (update)

5:48 AM MDT | September 17, 2010 | Deepti Ramesh

Biopharmaceutical company Crucell (Leiden, Netherlands) says that it is in advanced negotiations with Johnson & Johnson (J&J; New Brunswick, NJ), for a potential public offer by J&J for all outstanding ordinary shares of Crucell that it does not already own. In September 2009, J&J has purchased about 18% of Crucell’s ordinary shares for a total purchase price of €302 million ($396 million). J&J or an affiliate will acquire all outstanding equity of Crucell that it does not already own for about €1.75 billion, which represents a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa